Researchers Say Cannabis Based Drug May Provide Resistance to SARS-CoV-2

Saturday, May 16, 2020
By Paul Martin

Matt Agorist
May 16, 2020

Researchers at the University of Lethbridge in Alberta, Canada have concluded a study they say shows cannabis may provide resistance to SARS-CoV-2. Their preliminary findings came up during broader research into the use of cannabis to treat cancer.

It is important to point out that this study has not yet been peer reviewed. However, if their findings are correct, researchers say that cannabis works in a similar way to nicotine.

In a study out of the Institut Pasteur in France, researchers led by Jean-Pierre Changeux, a neurobiologist at the university, found the potential of nicotine patches in preventing infections from SARS-CoV-2.

The French study assumes that nicotine can protect against the new coronavirus based on the hypothesis “that nicotine attaches to cell receptors (ACE2) used by the coronavirus, thereby preventing the virus from attaching,” explains Changeux.

And, now, preliminary research is emerging out of Canada that certain strains of cannabis may also increase resistance to the coronavirus.

“The results on COVID-19 came from our studies on arthritis, Crohn’s disease, cancer and others,” says Dr. Igor Kovalchuck, a professor of Biological Sciences at the University of Lethbridge, in an email to DW.

The Rest…HERE

Leave a Reply

Join the revolution in 2018. Revolution Radio is 100% volunteer ran. Any contributions are greatly appreciated. God bless!

Follow us on Twitter